Patient Leaflet Updated 22-Jul-2021 | Alliance Pharmaceuticals
Anbesol Liquid
ANBESOL® Liquid
Lidocaine Hydrochloride, Chlorocresol and Cetylpyridinium Chloride
Read all of this leaflet carefully before using this medicine as it contains important information for you.
1. What Anbesol Liquid is and what it is used for
2. What you need to know before you use Anbesol Liquid
3. How to use Anbesol Liquid
4. Possible side effects
5. How to store Anbesol Liquid
6. Contents of pack and other information
Anbesol Liquid contains 0.9%w/w of lidocaine hydrochloride, 0.1%w/w of chlorocresol and 0.02%w/w of cetylpyridinium chloride.
Lidocaine hydrochloride is a local anaesthetic which works by stopping the sensation of pain. Chlorocresol and cetylpyridinium chloride kill bacteria.
Anbesol Liquid is used to help relieve pain and discomfort associated with teething, in children from 5 months of age, when other non-medicinal methods such as massaging of the gums or use of teething rings do not provide necessary relief.
The product may also be used by adults, children and the elderly for the temporary relief of pain caused by recurrent mouth ulcers and denture irritation.
Do not use more Anbesol Liquid than recommended (as listed in Section 3) as this may result in the active ingredients being absorbed into the body causing serious side effects, such as convulsions (fits).
Talk to your doctor or pharmacist before using Anbesol Liquid:
Tell your doctor or pharmacist if you are taking, have recently taken or might take any of the following medicines as they may interfere with Anbesol Liquid:
If you are pregnant, breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
If you are breast-feeding, small amounts of the active ingredient lidocaine will pass into your breast milk but in such small quantities that it should not harm your baby if this medicine is used as directed.
Anbesol Liquid is unlikely to affect your ability to drive or use machines.
This medicine contains chlorocresol and the azo dyes amaranth (E123) and sunset yellow (E110) which may cause allergic reactions.
This medicine contains 151 mg of alcohol (ethanol) in each dose (0.25 ml), which is equivalent to 604 mg/ ml (65.6% w/v). The amount in 0.25 ml of this medicine is equivalent to 4 ml beer or 2 ml wine.
The amount of alcohol in this medicine is not likely to have an effect in adults and adolescents, and its effects in children are not likely to be noticeable. It may have some effects in younger children, for example feeling sleepy.
The alcohol in this medicine may alter the effects of other medicines. Talk to your doctor or pharmacist if you are taking other medicines.
Follow these instructions carefully and never change the dose yourself. Do not exceed the stated dose.
If anyone used more Anbesol Liquid than they should, or if large quantities of the liquid are accidentally swallowed, contact your doctor or your nearest Accident and Emergency department, taking this leaflet and pack with you.
Like all medicines, this medicine may cause side effects, although not everybody gets them.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at:www.mhra.gov.uk/yellowcard, or search for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects you can help provide more information on the safety of this medicine.
Anbesol Liquid contains the active ingredients; lidocaine hydrochloride 0.90%w/w, chlorocresol 0.10%w/w and cetylpyridinium chloride 0.02%w/w.
It also contains alcohol (96%), menthol, glycerol, caramel colouring (comprised of quinoline yellow (E104), amaranth (E123), sunset yellow (E110) and green S (E142) and purified water.
Anbesol Liquid is a clear yellow liquid for oromucosal use supplied in bottles containing 5ml, 10ml or 15ml.
Not all pack sizes may be marketed.
Marketing Authorisation Holder:
Manufactured by:
This leaflet was last revised in March 2021.
Anbesol, Alliance and associated devices are registered trademarks of Alliance Pharmaceuticals Limited.
(C) Alliance Pharmaceuticals Limited 2021
Anbesol Liquid PIL UK 009
Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB
+44 (0)1249 466 977
+44 (0)1249 466 966
http://www.alliancepharma.co.uk